Advertisement

TipRanks Clinical-Trials-Auto-Generated Newsdesk

TipRanks Reporter

TipRanks’s Recent Articles

AbbVie’s ABBV-438 Myeloma Trial: Early-Stage Bet on Long-Term Oncology Growth

AbbVie’s ABBV-438 Myeloma Trial: Early-Stage Bet on Long-Term Oncology Growth

Abbvie ($ABBV) announced an update on their ongoing clinical study. The Phase 1 AbbVie study, officially titled “A...

2d ago

AstraZeneca Targets Early Detection in China With New ATTR Heart Disease Study

AstraZeneca Targets Early Detection in China With New ATTR Heart Disease Study

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The AstraZeneca study “A Prospective, Multicenter, Intervention...

2d ago

Haleon’s New Sensitivity Toothpaste Trial in China: What Investors Should Watch

Haleon’s New Sensitivity Toothpaste Trial in China: What Investors Should Watch

Haleon PLC Sponsored ADR ($HLN) announced an update on their ongoing clinical study. Haleon PLC (HLN) has completed...

2d ago

Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY

Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The FIRST-2.0 China study, officially titled “Finerenone...

2d ago

AstraZeneca Completes Early Imaging Study in Crohn’s Disease, Nudging Pipeline Hopes for AZN

AstraZeneca Completes Early Imaging Study in Crohn’s Disease, Nudging Pipeline Hopes for AZN

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca has completed a small Phase I positron...

2d ago

Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push

Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda Pharmaceutical Co. (TAK) has completed...

6d ago

Novo Nordisk’s EVOKE Alzheimer’s Trial: What the Latest Update Means for NVO Investors

Novo Nordisk’s EVOKE Alzheimer’s Trial: What the Latest Update Means for NVO Investors

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The EVOKE study, officially titled “A Randomised...

6d ago

Amgen’s FORWARD II Gout Study: What a Less Frequent Krystexxa Schedule Could Mean for Investors

Amgen’s FORWARD II Gout Study: What a Less Frequent Krystexxa Schedule Could Mean for Investors

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s FORWARD II Phase 4 study, officially...

6d ago

Bayer Targets India Hemophilia Market With New Real World Safety Study

Bayer Targets India Hemophilia Market With New Real World Safety Study

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer is launching a new real world...

8d ago

Biomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes

Biomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes

Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. Biomea Fusion Inc. is moving ahead...

8d ago

AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study

AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The ROSY-F roll-over study from AstraZeneca (AZN)...

8d ago

Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story

Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story

Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. The Phase 2 trial called “A...

8d ago

Nurix Advances NX-5948 Into Phase 3 Head-to-Head Battle in CLL/SLL

Nurix Advances NX-5948 Into Phase 3 Head-to-Head Battle in CLL/SLL

Nurix Therapeutics, Inc. ($NRIX) announced an update on their ongoing clinical study. The phase 3 study “A Phase...

8d ago

Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers

Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers

Arovella Therapeutics Limited ($AU:ALA) announced an update on their ongoing clinical study. The Phase 1 study “A Phase...

8d ago

Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study

Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study

Zealand Pharma A/S ($ZLDPF) announced an update on their ongoing clinical study. Zealand Pharma A/S (ZLDPF) has completed...

8d ago

Astellas’ Menopause Drug Fezolinetant Hits Key Safety Milestone in Japan

Astellas’ Menopause Drug Fezolinetant Hits Key Safety Milestone in Japan

Astellas Pharma ($ALPMF) announced an update on their ongoing clinical study. Astellas Menopause Study in Japan: What Investors...

8d ago

ESPERANZA Update: Real-World Data Study Could Broaden AstraZeneca’s T-DXd Cancer Opportunity

ESPERANZA Update: Real-World Data Study Could Broaden AstraZeneca’s T-DXd Cancer Opportunity

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The ESPERANZA study, officially titled “External Control Arm...

8d ago

Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment

Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has filed a new...

9d ago

Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know

Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is advancing a new...

9d ago

AbbVie’s Real‑World Parkinson’s Study in Belgium: What Investors Should Watch

AbbVie’s Real‑World Parkinson’s Study in Belgium: What Investors Should Watch

Abbvie ($ABBV) announced an update on their ongoing clinical study. The AbbVie (ABBV) study “Observational Prospective Study to...

9d ago

Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors

Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors

Ionis Pharmaceuticals Inc. ($IONS) announced an update on their ongoing clinical study. Ionis Expands Pediatric Trial of Donidalorsen...

9d ago

Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial

Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial

Suven Life Sciences Limited ($IN:SUVEN) announced an update on their ongoing clinical study. The Phase 2b study “A...

9d ago

SUVEN’s SUVN-I6107 Clears First-In-Human Hurdle: What Phase 1 Completion Means for Investors

SUVEN’s SUVN-I6107 Clears First-In-Human Hurdle: What Phase 1 Completion Means for Investors

Suven Life Sciences Limited ($IN:SUVEN) announced an update on their ongoing clinical study. Suven Life Sciences Ltd. (SUVEN)...

9d ago

GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch

GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch

GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline has launched a Phase 1, first‑in‑human study...

10d ago

BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis

BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb (BMY) has launched a...

10d ago

Argenx Completes Key CIDP Switch Study, Setting Up Next Steps for Efgartigimod

Argenx Completes Key CIDP Switch Study, Setting Up Next Steps for Efgartigimod

Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) has completed a Phase 4 study...

10d ago

Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study

Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The new Amgen Inc. rollover study, officially...

13d ago

Moderna Advances Phase 3 H5 Bird Flu Shot, Expanding Its Pandemic Vaccine Pipeline

Moderna Advances Phase 3 H5 Bird Flu Shot, Expanding Its Pandemic Vaccine Pipeline

Moderna ($MRNA) announced an update on their ongoing clinical study. Moderna (MRNA) is advancing a large Phase 3...

13d ago

EssilorLuxottica Deepens Myopia Insights With New Teen Behavior Study

EssilorLuxottica Deepens Myopia Insights With New Teen Behavior Study

Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilor International, part of EssilorLuxottica (OTC: ESLOY),...

13d ago

Organogenesis Advances NuShield Trial in Tough-to-Heal Leg Ulcers: What Investors Should Watch

Organogenesis Advances NuShield Trial in Tough-to-Heal Leg Ulcers: What Investors Should Watch

Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Organogenesis Holdings (ORGO) is sponsoring a new...

13d ago

AstraZeneca Completes Early Obesity Trial for AZD6234, Nudging Long-Term Growth Hopes

AstraZeneca Completes Early Obesity Trial for AZD6234, Nudging Long-Term Growth Hopes

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca (~AZN) has updated a Phase I clinical...

13d ago

AbbVie’s Real-World Migraine Study Nears Data Release: What Investors Should Watch

AbbVie’s Real-World Migraine Study Nears Data Release: What Investors Should Watch

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has completed a real world study...

13d ago

Eli Lilly’s LY4060874 Phase 1 Readout: What a Quiet Pipeline Update Means for LLY Investors

Eli Lilly’s LY4060874 Phase 1 Readout: What a Quiet Pipeline Update Means for LLY Investors

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The phase 1 trial “A...

13d ago

AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates

AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Tests Cancer Drug Mix for Safety...

14d ago

Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs

Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer’s latest U.S. study, “Identifying Post ICU...

14d ago

Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next

Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The Phase 1 study “A Phase 1...

14d ago

Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa

Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The Double-DARE study from Bayer aims to...

15d ago

ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors

ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors

Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. The study, titled “Phase 1, First-in-human,...

15d ago

Ipsen’s Luminaria Study: Fresh Digital Symptom Data in Primary Biliary Cholangitis

Ipsen’s Luminaria Study: Fresh Digital Symptom Data in Primary Biliary Cholangitis

Ipsen ($GB:0MH6) announced an update on their ongoing clinical study. The Luminaria study, officially titled “A Multicenter Non-interventional...

15d ago

Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story

Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story

Alnylam Pharmaceuticals ($ALNY) announced an update on their ongoing clinical study. The DemonsTTRate study is a long-term, real-world...

16d ago

Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects

Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer (BAYRY) is running ACO-REAL, a non-interventional...

16d ago

Teleflex Advances Long Coronary Stent Study, Keeping Cardiology Investors Watching

Teleflex Advances Long Coronary Stent Study, Keeping Cardiology Investors Watching

Teleflex ($TFX) announced an update on their ongoing clinical study. The Teleflex study, officially titled “A Prospective Multicenter...

16d ago

Pfizer’s Swedish Ibrance Study: Fresh Real‑World Data Signal for PFE Investors

Pfizer’s Swedish Ibrance Study: Fresh Real‑World Data Signal for PFE Investors

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running an observational...

16d ago

Haleon’s New Toothpaste Trial Could Brighten Both Smiles and Earnings

Haleon’s New Toothpaste Trial Could Brighten Both Smiles and Earnings

Haleon PLC ($GB:HLN) announced an update on their ongoing clinical study. Haleon PLC (HLN) has completed an exploratory...

16d ago

Novo Nordisk Advances New Obesity and Diabetes Drug With Key China Study Completion

Novo Nordisk Advances New Obesity and Diabetes Drug With Key China Study Completion

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The Novo Nordisk A/S study titled “Investigation...

16d ago

Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth

Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron (REGN) and Bayer have completed a...

16d ago

Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors

Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors

Revolution Medicines, Inc. ($RVMD), Summit Therapeutics PLC ($SMMT) announced an update on their ongoing clinical study. The Phase...

17d ago

Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch

Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch

Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. (VRTX) is running...

17d ago

NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors

NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors

NovoCure Ltd. ($NVCR) announced an update on their ongoing clinical study. The EF-32 pivotal study tests NovoCure Ltd.’s...

17d ago

AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real‑World Data Could Mean for AZN Investors

AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real‑World Data Could Mean for AZN Investors

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The OPTIMISE-CKD Spain Part 2 study, officially...

20d ago